Methyl 4-bromo-6-chloro-1h-indole-2-carboxylate

Catalog No.: 
ACGFNT182
CAS No.: 
1430229-84-7
Molecular Formula: 
C10H7BrClNO2
Molecular Weight: 
288.53
Methyl 4-bromo-6-chloro-1h-indole-2-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$301.00InquiryInquiry
100mg95%$441.00InquiryInquiry
250mg95%$621.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl 4-bromo-6-chloro-1h-indole-2-carboxylate
IUPAC Namemethyl 4-bromo-6-chloro-1H-indole-2-carboxylate
MDL No.MFCD24129643
Molecular FormulaC10H7BrClNO2
Molecular Weight288.53
SMILESO=C(C(N1)=CC2=C1C=C(Cl)C=C2Br)OC
InChI KeyGJROWFCXCULKFK-UHFFFAOYSA-N
Synonym1H-Indole-2-carboxylic acid, 4-bromo-6-chloro-, methyl ester;Methyl 4-bromo-6-chloro-1H-indole-2-carboxylate;Methyl 4-Bromo-6-chloroindole-2-carboxylate
CAS No.1430229-84-7

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACGFNT182 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACGFNT182 route product structure diagram
    ACGFNT1821430229-84-7
Inquiry

2. ACGFNT182 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACGFNT182 route product structure diagram
    ACGFNT1821430229-84-7
Inquiry

3. ACGFNT182 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACGFNT182 route product structure diagram
    ACGFNT1821430229-84-7
Inquiry

Comments (0)